After extensive clinical trials FDA approved Metronidazole – Flagyl and can be administered orally, topical or intravenously. In oral form, it is absorbed and passes in traffic where it has a half-life of 6 to 8 hours. The drug enters the cerebrospinal fluid. Treatment by Metronidazole crosses the placental barrier; it must be used with caution during pregnancy. In the US, there was a contra-indication in the 1st quarter, unless no other treatment was available.

Metronidazole – Flagyl is an antibiotic and anti-owned nitroimidazoles. The pill after ingestion inhibits the synthesis of nucleic acids and is used for the treatment of infections associated with anaerobic bacteria and protozoa. It is effective against, among others: Giardia, lamblia, Entamoeba histolytica, Clostridium difficile, Trichomonas vaginalis and Helicobacter pylori. Metronidazole is used in the treatment of colitis pseudomenbraneuses, which is why you can find it in combination with other antibiotics such as macrolides family may cause this type of disease. Metronidazole as an antibiotic is also prescribed for the treatment of Rosaceae (type Erythrogel or Rozagel) and télangiéctasies.

Metronidazole – Flagyl mainly been used in women with risks of preterm child birth. The risks associated with this medicine include some fetus related complexities.